Cel-Sci
CVM
#10549
Rank
โ‚ฌ18.12 M
Marketcap
1,04ย โ‚ฌ
Share price
-0.84%
Change (1 day)
-82.22%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚ฌ7.48 Million

According to Cel-Sci 's latest financial reports the company's total debt is โ‚ฌ7.48 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-09-30โ‚ฌ7.99 M-23.38%
2024-09-30โ‚ฌ10.43 M-18.6%
2023-09-30โ‚ฌ12.81 M-18.03%
2022-09-30โ‚ฌ15.64 M13.34%
2021-09-30โ‚ฌ13.79 M16.1%
2020-09-30โ‚ฌ11.88 M-4.09%
2019-09-30โ‚ฌ12.39 M7.49%
2018-09-30โ‚ฌ11.52 M-4.71%
2017-09-30โ‚ฌ12.09 M4.23%
2016-09-30โ‚ฌ11.6 M-6.61%
2015-09-30โ‚ฌ12.43 M1299.59%
2014-09-30โ‚ฌ0.88 M6%
2013-09-30โ‚ฌ0.83 M-2.8%
2012-09-30โ‚ฌ0.86 M-76.6%
2011-09-30โ‚ฌ3.68 M354.46%
2010-09-30โ‚ฌ0.81 M6.25%
2009-09-30โ‚ฌ0.76 M434.61%
2008-09-30โ‚ฌ0.14 M
2005-09-30โ‚ฌ0 M3.31%
2004-09-30โ‚ฌ0 M-99.68%
2003-09-30โ‚ฌ0.75 M-58.46%
2002-09-30โ‚ฌ1.8 M5170.36%
2001-09-30โ‚ฌ0.03 M21.63%
2000-09-30โ‚ฌ0.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ48.33 B 645,876.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ50.39 B 673,319.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.15 B 1,957.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ1.17 M-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.86 B 198,520.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.71 B 9,506.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B 6,638.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ0.34 M-95.43%๐Ÿ‡บ๐Ÿ‡ธ USA